ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that the Company will present at the 12th Annual BIO CEO & Investor Conference on Tuesday, February 9th at 9:30 a.m. Eastern time (6:30 a.m. Pacific time) at the Waldorf-Astoria in New York. The BIO CEO & Investor Conference is the largest conference focused on publicly traded biotechnology companies and provides participating companies with the opportunity to present to industry analysts, institutional investors, and business development and partnering executives. For more information visit www.ceo.bio.org.
